Pharmafile Logo

OPEN Health attend day 2 of the ECRD2020 congress

May 15, 2020 | ECRD, Virtual events, rare disease 

Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access.

Day 2 of the 10th  ECRD2020 congress is under way. Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access. The review of all sessions at the end of the day will also be very useful as there is a lot going on through the various streams.

Sustenance today will be cold brew coffee (who has time to boil a kettle), English muffins, jaffa cakes and pistachio ice cream (it’s Friday!). Gavin recognises that people may be more interested in what Eddie is up to. After the excitement of day one he has taken to his bed!

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office

OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, announced a new team of experts will lead its HEOR & Market Access Scientific Office.

OPEN Health Appoints Richard Jones as President for Evidence & Access

OPEN Health is pleased to announce the appointment of Richard Jones as President for Evidence & Access.

Drive, Discover, Dive_OPEN Health

Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.

Novel Oncology Therapies Require Innovative Methods in Oncology Modeling

Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.

The CM Group rebrands to OPEN Health

Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding...

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.

Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access

OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.

OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital

OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical...

How digital health is changing the relationship between patients and health providers | OPEN Health

The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes